Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation.

Protonotarios A, Elliott PM.

Int J Cardiol. 2018 Jul 2. pii: S0167-5273(18)33478-8. doi: 10.1016/j.ijcard.2018.06.117. [Epub ahead of print] No abstract available.

PMID:
29983250
2.

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease.

Limongelli G, Masarone D, Verrengia M, Gravino R, Salerno G, Castelletti S, Rubino M, Marrazzo T, Pisani A, Cecchi F, Elliott PM, Pacileo G.

J Cardiovasc Echogr. 2018 Apr-Jun;28(2):120-123. doi: 10.4103/jcecho.jcecho_2_18.

3.

Anderson-Fabry disease in heart failure.

Akhtar MM, Elliott PM.

Biophys Rev. 2018 Jun 16. doi: 10.1007/s12551-018-0432-5. [Epub ahead of print] Review.

4.

Outcomes following the surgical management of left ventricular outflow tract obstruction; A systematic review and meta-analysis.

Collis RA, Rahman MS, Watkinson O, Guttmann OP, O'Mahony C, Elliott PM.

Int J Cardiol. 2018 Aug 15;265:62-70. doi: 10.1016/j.ijcard.2018.01.130.

PMID:
29885701
5.

Assessment of a conduction-repolarisation metric to predict Arrhythmogenesis in right ventricular disorders.

Martin CA, Orini M, Srinivasan NT, Bhar-Amato J, Honarbakhsh S, Chow AW, Lowe MD, Ben-Simon R, Elliott PM, Taggart P, Lambiase PD.

Int J Cardiol. 2018 May 20. pii: S0167-5273(18)32049-7. doi: 10.1016/j.ijcard.2018.05.063. [Epub ahead of print]

6.

The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts.

Spada M, Baron R, Elliott PM, Falissard B, Hilz MJ, Monserrat L, Tøndel C, Tylki-Szymańska A, Wanner C, Germain DP.

Mol Genet Metab. 2018 Apr 26. pii: S1096-7192(18)30186-0. doi: 10.1016/j.ymgme.2018.04.007. [Epub ahead of print] Review.

PMID:
29785937
7.

Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy.

Wanner C, Germain DP, Hilz MJ, Spada M, Falissard B, Elliott PM.

Mol Genet Metab. 2018 Apr 11. pii: S1096-7192(17)30589-9. doi: 10.1016/j.ymgme.2018.04.004. [Epub ahead of print] No abstract available.

PMID:
29724657
8.

2018 ESC Guidelines for the diagnosis and management of syncope.

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group .

Eur Heart J. 2018 Jun 1;39(21):1883-1948. doi: 10.1093/eurheartj/ehy037. No abstract available.

PMID:
29562304
9.

Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope.

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group .

Eur Heart J. 2018 Jun 1;39(21):e43-e80. doi: 10.1093/eurheartj/ehy071. No abstract available.

PMID:
29562291
10.

On the Road from Gene to Therapy in Inherited Cardiomyopathies.

Limongelli G, Bossone E, Elliott PM, Day SM.

Heart Fail Clin. 2018 Apr;14(2):xi-xv. doi: 10.1016/j.hfc.2018.01.003. No abstract available.

PMID:
29525651
11.

Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.

Masarone D, Kaski JP, Pacileo G, Elliott PM, Bossone E, Day SM, Limongelli G.

Heart Fail Clin. 2018 Apr;14(2):119-128. doi: 10.1016/j.hfc.2017.12.007. Review.

PMID:
29525641
12.

Transforming care for rare and inherited cardiovascular diseases through education and training.

Elliott PM, Camici P.

Int J Cardiol. 2018 Apr 15;257:342-343. doi: 10.1016/j.ijcard.2018.01.035. No abstract available.

PMID:
29506728
13.

Multifocal ectopic Purkinje-related premature contractions: Sorting the wheat from the chaff.

Elliott PM.

Int J Cardiol. 2018 Apr 15;257:218-219. doi: 10.1016/j.ijcard.2018.01.024. No abstract available.

PMID:
29506695
14.

Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene Ontology.

Lovering RC, Roncaglia P, Howe DG, Laulederkind SJF, Khodiyar VK, Berardini TZ, Tweedie S, Foulger RE, Osumi-Sutherland D, Campbell NH, Huntley RP, Talmud PJ, Blake JA, Breckenridge R, Riley PR, Lambiase PD, Elliott PM, Clapp L, Tinker A, Hill DP.

Circ Genom Precis Med. 2018 Feb;11(2):e001813. doi: 10.1161/CIRCGEN.117.001813.

15.

Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.

Arends M, Biegstraaten M, Wanner C, Sirrs S, Mehta A, Elliott PM, Oder D, Watkinson OT, Bichet DG, Khan A, Iwanochko M, Vaz FM, van Kuilenburg ABP, West ML, Hughes DA, Hollak CEM.

J Med Genet. 2018 May;55(5):351-358. doi: 10.1136/jmedgenet-2017-104863. Epub 2018 Feb 7.

16.

The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies.

Charron P, Elliott PM, Gimeno JR, Caforio ALP, Kaski JP, Tavazzi L, Tendera M, Maupain C, Laroche C, Rubis P, Jurcut R, Calò L, Heliö TM, Sinagra G, Zdravkovic M, Kavoliuniene A, Felix SB, Grzybowski J, Losi MA, Asselbergs FW, García-Pinilla JM, Salazar-Mendiguchia J, Mizia-Stec K, Maggioni AP; EORP Cardiomyopathy Registry Investigators .

Eur Heart J. 2018 May 21;39(20):1784-1793. doi: 10.1093/eurheartj/ehx819.

PMID:
29378019
17.

Evolving Story of Clinical Trials in Hypertrophic Cardiomyopathy.

Elliott PM.

Circ Heart Fail. 2018 Jan;11(1):e004572. doi: 10.1161/CIRCHEARTFAILURE.117.004572. No abstract available.

PMID:
29321133
18.

Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.

Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM.

Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):757-767. doi: 10.1093/ehjci/jex340.

PMID:
29319785
19.

Individualized surgical strategies for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Collis R, Tsang V, Pantazis A, Tome-Esteban M, Elliott PM, McGregor CGA.

Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1237-1243. doi: 10.1093/ejcts/ezx458.

PMID:
29293974
20.

Evolving concepts in dilated cardiomyopathy.

Merlo M, Cannatà A, Gobbo M, Stolfo D, Elliott PM, Sinagra G.

Eur J Heart Fail. 2018 Feb;20(2):228-239. doi: 10.1002/ejhf.1103. Epub 2017 Dec 22. Review.

PMID:
29271570
21.

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).

O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin SA, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud KD, Vermeer A, Wilde A, Favalli V, Guttmann OP, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM.

Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.

PMID:
29191938
22.

Lamin and the heart.

Captur G, Arbustini E, Bonne G, Syrris P, Mills K, Wahbi K, Mohiddin SA, McKenna WJ, Pettit S, Ho CY, Muchir A, Gissen P, Elliott PM, Moon JC.

Heart. 2018 Mar;104(6):468-479. doi: 10.1136/heartjnl-2017-312338. Epub 2017 Nov 25. Review.

PMID:
29175975
23.

Early and medium-term outcomes of Alfieri mitral valve repair in the management of systolic anterior motion during septal myectomy.

Collis R, Watkinson O, Pantazis A, Tome-Esteban M, Elliott PM, McGregor CGA.

J Card Surg. 2017 Nov;32(11):686-690. doi: 10.1111/jocs.13239. Epub 2017 Nov 23.

PMID:
29168204
24.

Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Collis R, Watkinson O, O'Mahony C, Guttmann OP, Pantazis A, Tome-Esteban M, Tsang V, Chandrasekaran V, McGregor CGA, Elliott PM.

Eur J Heart Fail. 2018 Feb;20(2):398-405. doi: 10.1002/ejhf.1038. Epub 2017 Nov 16.

PMID:
29148156
25.

Isolated aortic root dilation in homocystinuria.

Lorenzini M, Guha N, Davison JE, Pitcher A, Pandya B, Kemp H, Lachmann R, Elliott PM, Murphy E.

J Inherit Metab Dis. 2018 Jan;41(1):109-115. doi: 10.1007/s10545-017-0094-7. Epub 2017 Oct 4.

26.

Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.

Masarone D, Duro G, Dellegrottaglie S, Colomba P, Rubino M, Cirillo A, Pisani A, Caiazza M, Elliott PM, Calabrò P, Pacileo G, Limongelli G.

Future Cardiol. 2017 Nov;13(6):521-527. doi: 10.2217/fca-2017-0011. Epub 2017 Sep 22.

PMID:
28936893
27.

Fabry Disease: A Rare Condition Emerging From the Darkness.

Elliott PM.

Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001862. doi: 10.1161/CIRCGENETICS.117.001862. No abstract available.

PMID:
28798027
28.

Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.

Arends M, Biegstraaten M, Hughes DA, Mehta A, Elliott PM, Oder D, Watkinson OT, Vaz FM, van Kuilenburg ABP, Wanner C, Hollak CEM.

PLoS One. 2017 Aug 1;12(8):e0182379. doi: 10.1371/journal.pone.0182379. eCollection 2017.

29.

Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.

Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U, Felix SB, Garcia-Pavia P, Hachulla E, Heymans S, Imazio M, Klingel K, Marcolongo R, Matucci Cerinic M, Pantazis A, Plein S, Poli V, Rigopoulos A, Seferovic P, Shoenfeld Y, Zamorano JL, Linhart A.

Eur Heart J. 2017 Sep 14;38(35):2649-2662. doi: 10.1093/eurheartj/ehx321. No abstract available.

PMID:
28655210
30.

Rare Disease in Cardiovascular Medicine I.

Majid Akhtar M, Elliott PM.

Eur Heart J. 2017 Jun 1;38(21):1625-1628. doi: 10.1093/eurheartj/ehx241. No abstract available.

PMID:
28575386
31.

Sudden cardiac death in inherited cardiomyopathy.

Collis R, Elliott PM.

Int J Cardiol. 2017 Jun 15;237:56-59. doi: 10.1016/j.ijcard.2017.04.006. Review.

PMID:
28532587
32.

Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.

Norrish G, Cantarutti N, Pissaridou E, Ridout DA, Limongelli G, Elliott PM, Kaski JP.

Eur J Prev Cardiol. 2017 Jul;24(11):1220-1230. doi: 10.1177/2047487317702519. Epub 2017 May 9. Review.

PMID:
28482693
33.

Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy.

Srinivasan NT, Patel KH, Qamar K, Taylor A, Bacà M, Providência R, Tome-Esteban M, Elliott PM, Lambiase PD.

Circ Arrhythm Electrophysiol. 2017 Apr;10(4). pii: e004801. doi: 10.1161/CIRCEP.117.004801.

34.

Community delivery of semiautomated fractal analysis tool in cardiac mr for trabecular phenotyping.

Captur G, Radenkovic D, Li C, Liu Y, Aung N, Zemrak F, Tobon-Gomez C, Gao X, Elliott PM, Petersen SE, Bluemke DA, Friedrich MG, Moon JC.

J Magn Reson Imaging. 2017 Oct;46(4):1082-1088. doi: 10.1002/jmri.25644. Epub 2017 Feb 2.

PMID:
28152235
35.

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.

Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, Elliott PM, Linthorst GE, Wijburg FA, Biegstraaten M, Hollak CE.

J Am Soc Nephrol. 2017 May;28(5):1631-1641. doi: 10.1681/ASN.2016090964. Epub 2016 Dec 15.

36.

Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.

Rosmini S, Biagini E, O'Mahony C, Bulluck H, Ruozi N, Lopes LR, Guttmann O, Reant P, Quarta CC, Pantazis A, Tome-Esteban M, Mckenna WJ, Rapezzi C, Elliott PM.

Heart. 2017 Feb 15;103(4):300-306. doi: 10.1136/heartjnl-2016-310138. Epub 2016 Oct 24.

PMID:
27798053
37.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
38.

The embryological basis of subclinical hypertrophic cardiomyopathy.

Captur G, Ho CY, Schlossarek S, Kerwin J, Mirabel M, Wilson R, Rosmini S, Obianyo C, Reant P, Bassett P, Cook AC, Lindsay S, McKenna WJ, Mills K, Elliott PM, Mohun TJ, Carrier L, Moon JC.

Sci Rep. 2016 Jun 21;6:27714. doi: 10.1038/srep27714.

39.

Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy.

O'Mahony C, Jichi F, Monserrat L, Ortiz-Genga M, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators*.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003818. doi: 10.1161/CIRCEP.115.003818.

40.

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].

Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; Task Force per il Trattamento dei Pazienti con Aritmie Ventricolari e la Prevenzione della Morte Cardiaca Improvvisa della Società Europea di Cardiologia.

G Ital Cardiol (Rome). 2016 Feb;17(2):108-70. doi: 10.1714/2174.23496. Italian. No abstract available.

PMID:
27029760
41.

Hypertrophic Cardiomyopathy: Job Done or Work in Progress?

Elliott PM.

J Am Coll Cardiol. 2016 Mar 29;67(12):1410-1411. doi: 10.1016/j.jacc.2016.02.009. No abstract available.

42.

2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):176. doi: 10.1016/j.rec.2016.01.001. No abstract available.

PMID:
26837728
43.

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P.

Eur Heart J. 2016 Jun 14;37(23):1850-8. doi: 10.1093/eurheartj/ehv727. Epub 2016 Jan 19. Review.

PMID:
26792875
44.

A Family History of Sudden Death Should Not Be a Primary Indication for an Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.

Watkinson OT, Elliott PM.

Can J Cardiol. 2015 Nov;31(11):1407-9. doi: 10.1016/j.cjca.2015.07.724. Epub 2015 Aug 12. Review.

PMID:
26518447
45.

Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing.

Nunn LM, Lopes LR, Syrris P, Murphy C, Plagnol V, Firman E, Dalageorgou C, Zorio E, Domingo D, Murday V, Findlay I, Duncan A, Carr-White G, Robert L, Bueser T, Langman C, Fynn SP, Goddard M, White A, Bundgaard H, Ferrero-Miliani L, Wheeldon N, Suvarna SK, O'Beirne A, Lowe MD, McKenna WJ, Elliott PM, Lambiase PD.

Europace. 2016 Jun;18(6):888-96. doi: 10.1093/europace/euv285. Epub 2015 Oct 25.

46.

Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.

Lopes LR, Murphy C, Syrris P, Dalageorgou C, McKenna WJ, Elliott PM, Plagnol V.

Eur J Med Genet. 2015 Nov;58(11):611-6. doi: 10.1016/j.ejmg.2015.10.001. Epub 2015 Oct 9.

PMID:
26455666
47.

Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.

Coats CJ, Rantell K, Bartnik A, Patel A, Mist B, McKenna WJ, Elliott PM.

Circ Heart Fail. 2015 Nov;8(6):1022-31. doi: 10.1161/CIRCHEARTFAILURE.114.002248. Epub 2015 Sep 15.

48.

Fractal frontiers in cardiovascular magnetic resonance: towards clinical implementation.

Captur G, Karperien AL, Li C, Zemrak F, Tobon-Gomez C, Gao X, Bluemke DA, Elliott PM, Petersen SE, Moon JC.

J Cardiovasc Magn Reson. 2015 Sep 7;17:80. doi: 10.1186/s12968-015-0179-0. Review.

49.

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; ESC Scientific Document Group .

Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29. No abstract available.

PMID:
26320108
50.

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC).

Europace. 2015 Nov;17(11):1601-87. doi: 10.1093/europace/euv319. Epub 2015 Aug 29. Review. No abstract available.

PMID:
26318695

Supplemental Content

Loading ...
Support Center